Thesemodels typically assume that all event sequences come from the same data distribution.

Statistical approaches [5] for the forecasting problem are fairly newcompared tomore traditional mechanistic approaches [13, 38].

Continuous-time event data are common in applications such as individual behavior data, financial transactions, and medical health records.

Riemannian representation learning typically relies on approximating densities on chosen manifolds. This involves optimizing difficult objectives, potentially harming models. To completely circumvent this issue, we introduce the Riemannian generative decoder which finds manifold-valued maximum likelihood latents with a Riemannian optimizer while training a decoder network. By discarding the encoder, we vastly simplify the manifold constraint compared to current approaches which often only handle few specific manifolds. We validate our approach on three case studies -- a synthetic branching diffusion process, human migrations inferred from mitochondrial DNA, and cells undergoing a cell division cycle -- each showing that learned representations respect the prescribed geometry and capture intrinsic non-Euclidean structure. Our method requires only a decoder, is compatible with existing architectures, and yields interpretable latent spaces aligned with data geometry.

Identifying gene splicing is a core and significant task confronted in modern collaboration between artificial intelligence and bioinformatics. Past decades have witnessed great efforts on this concern, such as the bio-plausible splicing pattern AT-CG and the famous SpliceAI. In this paper, we propose a novel framework for the task of gene splicing identification, named Horizon-wise Gene Splicing Identification (H-GSI). The proposed H-GSI follows the horizon-wise identification paradigm and comprises four components: the pre-processing procedure transforming string data into tensors, the sliding window technique handling long sequences, the SeqLab model, and the predictor. In contrast to existing studies that process gene information with a truncated fixed-length sequence, H-GSI employs a horizon-wise identification paradigm in which all positions in a sequence are predicted with only one forward computation, improving accuracy and efficiency. The experiments conducted on the real-world Human dataset show that our proposed H-GSI outperforms SpliceAI and achieves the best accuracy of 97.20\%. The source code is available from this link.

The intra- and inter-species genetic diversity of bacteria and the absence of 'reference', or the most representative, sequences of individual species present a significant challenge for sequence-based identification. The aims of this study were to determine the utility, and compare the performance of several clustering and classification algorithms to identify the species of 364 sequences of 16S rRNA gene with a defined species in GenBank, and 110 sequences of 16S rRNA gene with no defined species, all within the genus Nocardia. A total of 364 16S rRNA gene sequences of Nocardia species were studied. In addition, 110 16S rRNA gene sequences assigned only to the Nocardia genus level at the time of submission to GenBank were used for machine learning classification experiments. Different clustering algorithms were compared with a novel algorithm or the linear mapping (LM) of the distance matrix. Principal Components Analysis was used for the dimensionality reduction and visualization. Results: The LM algorithm achieved the highest performance and classified the set of 364 16S rRNA sequences into 80 clusters, the majority of which (83.52%) corresponded with the original species. The most representative 16S rRNA sequences for individual Nocardia species have been identified as 'centroids' in respective clusters from which the distances to all other sequences were minimized; 110 16S rRNA gene sequences with identifications recorded only at the genus level were classified using machine learning methods. Simple kNN machine learning demonstrated the highest performance and classified Nocardia species sequences with an accuracy of 92.7% and a mean frequency of 0.578.

Human genetic diseases often arise from point mutations, emphasizing the critical need for precise genome editing techniques. Among these, base editing stands out as it allows targeted alterations at the single nucleotide level. However, its clinical application is hindered by low editing efficiency and unintended mutations, necessitating extensive trial-and-error experimentation in the laboratory. To speed up this process, we present an attention-based two-stage machine learning model that learns to predict the likelihood of all possible editing outcomes for a given genomic target sequence. We further propose a multi-task learning schema to jointly learn multiple base editors (i.e. variants) at once. Our model's predictions consistently demonstrated a strong correlation with the actual experimental results on multiple datasets and base editor variants. These results provide further validation for the models' capacity to enhance and accelerate the process of refining base editing designs.

Human genetic diseases often arise from point mutations, emphasizing the critical need for precise genome editing techniques. Among these, base editing stands out as it allows targeted alterations at the single nucleotide level. However, its clinical application is hindered by low editing efficiency and unintended mutations, necessitating extensive trial-and-error experimentation in the laboratory. To speed up this process, we present an attention-based two-stage machine learning model that learns to predict the likelihood of all possible editing outcomes for a given genomic target sequence. We further propose a multi-task learning schema to jointly learn multiple base editors (i.e. variants) at once. Our model's predictions consistently demonstrated a strong correlation with the actual experimental results on multiple datasets and base editor variants. These results provide further validation for the models' capacity to enhance and accelerate the process of refining base editing designs.

Many of today's most urgent problems demand new molecules and materials, from antimicrobial drugs to fight superbugs and antivirals to treat novel pandemics to more sustainable photosensitive coatings for semiconductors and next-generation polymers to capture carbon dioxide right at its source. We can design these from scratch, using AI to expedite the otherwise expensive and slow process, or we can tweak existing molecules to fine-tune the properties we care about -- such as toxicity, activity, or stability. Starting from a known molecule is like getting a head start on the design and production of candidate molecules, as we know they have some of the characteristics we need, and we can use existing knowledge and manufacturing pipelines to synthesize and test them down the line. The challenge in this process, called molecular optimization, is that tweaking an existing molecule can produce a huge number of variants. They won't all have the desired properties, and evaluating them empirically to find those that do would take too much time and money to be feasible.